Manufacturer or GPO Program year 2023 Source: CMS Open Payments

Kiniksa Pharmaceuticals, Ltd.

Bermuda

CMS manufacturer 100000846825

Open in the dashboard

General payments

$1,375,932

20,352 payments

Research payments

$7,011,923

5,070 payments

Ownership & investment interest

$0

None reported

Through program year 2023, Kiniksa Pharmaceuticals, Ltd. reported paying $1,375,932 in general payments and $7,011,923 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2023 General $752,946 12,634
2023 Research $2,031,859 2,178
2022 General $366,596 4,934
2022 Research $2,531,831 1,372
2021 General $256,390 2,784
2021 Research $2,448,233 1,520

Breakdown

Top recipients General payments · program year 2023
  1. Robert Biederman Cardiovascular Disease · Charleston, SC $50,981 55 payments
  2. John Ryan Cardiovascular Disease · Salt Lake City, UT $41,207 41 payments
  3. Dipan Shah Cardiovascular Disease · Houston, TX $26,297 28 payments
  4. Ajit Raisinghani Cardiovascular Disease · San Diego, CA $26,006 30 payments
  5. Antonio Abbate Cardiovascular Disease · Charlottesville, VA $25,903 26 payments
  6. Arif Albulushi Advanced Heart Failure and Transplant Cardiology · Bellevue, NE $24,973 29 payments
  7. John Isaac Interventional Cardiology · Houston, TX $22,816 26 payments
  8. Krishnaswami Vijayaraghavan Cardiovascular Disease · Scottsdale, AZ $21,788 20 payments
  9. David Homan Interventional Cardiology · Opelousas, LA $14,761 18 payments
  10. Petros Efthimiou Rheumatology · New York, NY $14,595 16 payments
Top research recipients Research payments · program year 2023
  1. Dm Clinical Research $366,625 390 payments
  2. Southwest Rheumatology Research PA $163,507 146 payments
  3. Minneapolis Heart Institute Foundation $153,201 29 payments
  4. Rheumatology And Pulmonary Clinic $96,430 108 payments
  5. Millennium Research $95,947 114 payments
  6. Inland Rheumatology Clinical Trials INC $90,492 113 payments
  7. Dermatology Specialist of Spokane $74,288 9 payments
  8. University Of Rochester Medical Center $72,928 28 payments
  9. Wright State Physicians $67,568 17 payments
  10. Advanced Clinical Research Institute $65,055 17 payments
Products the payments named General payments · program year 2023
  1. Arcalyst Rheumatology $421,288 60% · 355 recipients
  2. Arcalyst Not Applicable $279,717 40% · 7,141 recipients

Each share is of this company’s general payments naming a product in 2023. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2023
  1. Cardiovascular Disease Internal Medicine $391,839 56% · 2,491 practitioners
  2. Interventional Cardiology Internal Medicine $86,825 12% · 930 practitioners
  3. Rheumatology Internal Medicine $36,987 5% · 443 practitioners
  4. Advanced Heart Failure and Transplant Cardiology Internal Medicine $36,045 5% · 68 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $24,538 4% · 744 practitioners

The top 5 of 83 specialties; each share is of this company’s general payments to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. California $91,568 12% · 909 recipients
  2. Texas $67,191 9% · 626 recipients
  3. Utah $57,306 8% · 44 recipients
  4. North Carolina $57,119 8% · 221 recipients
  5. New York $53,268 7% · 595 recipients

The top 5 of 52 states; each share is of this company’s general payments in 2023 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2021–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $439,710 146 payments
  2. Food and Beverage $436,761 19,759 payments
  3. Honoraria $142,180 54 payments
  4. Consulting Fee $121,445 64 payments
  5. Royalty or License $88,991 14 payments
  6. Travel and Lodging $80,961 293 payments
  7. Grant $45,900 12 payments
  8. Education $13,235 8 payments
  9. Space rental or facility fees (teaching hospital only) $6,750 2 payments
Companies with a similar name General payments · program years 2021–2023
  1. Kiniksa Pharmaceuticals International, plc Great Britain (UK) $1,744,693

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

20,352 general · 5,070 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record